Hillstar Bio. Inc.
- Biotech or pharma, therapeutic R&D
Hillstar Bio is revolutionizing autoimmune disease treatment through a precision-driven approach that selectively depletes pathogenic cells while preserving healthy ones. This method holds the promise of providing durable relief and improving patient outcomes compared to traditional immunosuppressive therapies. Additionally, the company's versatile approach leverages tailored discovery techniques for each therapeutic, free from the constraints of traditional drug development platforms.